Ocugen (OCGN) Gains from Investment Securities (2014 - 2025)
Ocugen (OCGN) reported Gains from Investment Securities of -$8000.0 for Q4 2025, up 11.11% on a YoY basis from -$7200.0 in Q4 2024, and down 100.6% quarter-over-quarter from $1.3 million in Q3 2025.
Ocugen (OCGN) Gains from Investment Securities (2014 - 2025) Analysis & Trends
Ocugen has reported Gains from Investment Securities for 12 years, with the latest figure at -$8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 11.11% year-over-year to -$8000.0; the trailing twelve-month figure through Mar 2026 stood at $880000.0 (up 120.0% YoY), and the FY2025 full-year result was $1.3 million, up 3635.14% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$8000.0, down from $1.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.3 million in Q3 2025, with the low at -$448000.0 in Q2 2025.
- Historically, Gains from Investment Securities has averaged $157750.0 across 5 years, with a median of -$7000.0 in 2021.
- The largest YoY upside for Gains from Investment Securities was 14944.44% in 2025 against a maximum downside of 4380.0% in 2025.
- Ocugen's Gains from Investment Securities stood at $10000.0 in 2021, then jumped by 6610.0% to $671000.0 in 2022, then slipped by 14.75% to $572000.0 in 2023, then sank by 101.57% to -$9000.0 in 2024, then rose by 11.11% to -$8000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$8000.0 (Q4 2025), $1.3 million (Q3 2025), and -$448000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -448,000.00 |
| Jun 30, 2025 | -448,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | 572,000.00 |
| Dec 31, 2023 | 572,000.00 |
| Sep 30, 2023 | 363,000.00 |
| Sep 30, 2023 | 363,000.00 |